Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
436,500
+22,000 (5.31%)
May 21, 2026, 3:30 PM KST

Hanmi Pharm. Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,255,9495,731,4573,556,8004,473,4213,711,1673,373,870
Market Cap Growth
73.07%61.14%-20.49%20.54%10.00%-23.27%
Enterprise Value
5,661,9356,103,4604,027,0464,935,3544,226,7784,030,879
Last Close Price
414500.00450353.37279478.14349622.87289351.69262307.54
PE Ratio
31.0233.8029.3230.5944.8350.34
Forward PE
27.5533.6419.5430.5738.0144.63
PS Ratio
3.403.702.383.002.792.80
PB Ratio
3.694.032.874.073.683.64
P/TBV Ratio
4.384.783.424.924.514.47
P/FCF Ratio
40.4244.0723.0623.6528.1418.54
P/OCF Ratio
30.3733.1218.3820.6622.8716.71
PEG Ratio
1.251.581.161.080.370.37
EV/Sales Ratio
3.663.942.693.313.173.35
EV/EBITDA Ratio
17.5518.9213.0015.2616.8618.79
EV/EBIT Ratio
25.2927.2618.9521.9527.4732.14
EV/FCF Ratio
43.5446.9326.1126.0932.0522.15
Debt / Equity Ratio
0.310.310.400.520.670.82
Debt / EBITDA Ratio
1.351.351.601.772.713.53
Debt / FCF Ratio
3.343.343.223.035.144.16
Net Debt / Equity Ratio
0.160.160.250.290.440.59
Net Debt / EBITDA Ratio
0.720.720.980.981.762.54
Net Debt / FCF Ratio
1.791.791.971.683.352.99
Asset Turnover
0.740.740.760.780.690.63
Inventory Turnover
2.072.072.302.382.372.04
Quick Ratio
0.900.900.630.610.620.67
Current Ratio
1.481.481.091.041.031.08
Return on Equity (ROE)
14.05%14.05%12.00%15.68%10.48%9.26%
Return on Assets (ROA)
6.73%6.73%6.78%7.35%4.98%4.11%
Return on Invested Capital (ROIC)
12.22%12.26%11.77%13.37%8.83%6.66%
Return on Capital Employed (ROCE)
14.60%14.60%15.90%18.80%12.30%9.70%
Earnings Yield
3.23%2.96%3.41%3.27%2.23%1.99%
FCF Yield
2.47%2.27%4.34%4.23%3.55%5.39%
Payout Ratio
18.20%18.20%10.35%12.31%7.24%8.77%
Buyback Yield / Dilution
-0.07%-0.07%0.08%0.09%0.12%0.11%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.